Exact Sciences Corporation Company Profile (NASDAQ:EXAS)

About Exact Sciences Corporation

Exact Sciences Corporation logoExact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: EXAS
  • CUSIP: 30063P10
Key Metrics:
  • Previous Close: $19.91
  • 50 Day Moving Average: $17.79
  • 200 Day Moving Average: $17.65
  • 52-Week Range: $108,410,000.00 - $4.67
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.92
  • P/E Growth: -0.53
  • Market Cap: $2.16B
  • Outstanding Shares: 108,410,000
  • Beta: 0.84
Profitability:
  • Net Margins: -216.45%
  • Return on Equity: -55.44%
  • Return on Assets: -49.29%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 11.94%
  • Quick Ratio: 11.69%
Additional Links:
Companies Related to Exact Sciences Corporation:

Analyst Ratings

Consensus Ratings for Exact Sciences Corporation (NASDAQ:EXAS) (?)
Ratings Breakdown: 6 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $19.91 (0.00% downside)

Analysts' Ratings History for Exact Sciences Corporation (NASDAQ:EXAS)
Show:
DateFirmActionRatingPrice TargetDetails
1/31/2017Craig HallumSet Price TargetBuy$26.00View Rating Details
1/23/2017Canaccord GenuitySet Price TargetBuy$24.00View Rating Details
1/8/2017BTIG ResearchReiterated RatingBuy$22.00View Rating Details
12/20/2016Robert W. BairdSet Price TargetBuy$22.00View Rating Details
11/1/2016Lake Street CapitalLower Price TargetHold$15.00 -> $8.00View Rating Details
10/26/2016Benchmark Co.Boost Price TargetHold$14.00 -> $17.00View Rating Details
10/4/2016Jefferies Group LLCBoost Price TargetBuy$20.00 -> $23.00View Rating Details
8/15/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$16.00 -> $18.00View Rating Details
8/1/2016Roth CapitalReiterated RatingHold$11.00 -> $15.00View Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$10.00 -> $15.00View Rating Details
7/15/2016William BlairReiterated RatingOutperform$29.00View Rating Details
2/25/2016StephensDowngradeOverweight -> Equal WeightView Rating Details
10/30/2015WedbushLower Price Target$7.00 -> $6.50View Rating Details
5/5/2015JMP SecuritiesBoost Price TargetOutperform$27.00 -> $31.00View Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Exact Sciences Corporation (NASDAQ:EXAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2017Q416($0.40)$32.53 millionN/AView Earnings Details
10/26/2016Q316($0.42)($0.36)$25.24 million$28.10 millionViewListenView Earnings Details
7/26/2016Q216($0.55)($0.46)$18.54 million$21.20 millionViewListenView Earnings Details
5/3/2016Q116($0.52)($0.49)$15.17 million$14.80 millionViewN/AView Earnings Details
2/24/2016Q415($0.47)($0.41)$14.96 million$14.40 millionViewListenView Earnings Details
10/29/2015Q315($0.44)($0.45)$12.56 million$12.60 millionViewListenView Earnings Details
7/20/2015Q215($0.45)($0.44)$7.96 million$8.10 millionViewListenView Earnings Details
5/4/2015Q115($0.41)($0.40)$4.11 million$4.30 millionViewN/AView Earnings Details
2/24/2015Q414($0.04)($0.38)$19.90 million$1.15 millionViewN/AView Earnings Details
10/27/2014Q314($0.32)($0.39)$0.13 millionViewListenView Earnings Details
7/22/2014Q214($0.25)($0.24)$0.03 millionViewN/AView Earnings Details
5/1/2014Q114($0.19)($0.23)$0.40 million$0.30 millionViewN/AView Earnings Details
2/20/2014Q413($0.19)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details
10/29/2013Q313($0.18)($0.16)$1.02 million$1.00 millionViewN/AView Earnings Details
7/23/2013Q2 2013($0.18)($0.19)$1.02 million$1.00 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.20)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details
2/20/2013Q4 2012($0.18)($0.22)$1.04 million$1.00 millionViewN/AView Earnings Details
10/30/2012Q312($0.21)($0.21)$1.03 million$1.04 millionViewN/AView Earnings Details
7/25/2012($0.20)($0.26)ViewN/AView Earnings Details
5/1/2012($0.18)($0.19)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/3/2011($0.15)($0.15)ViewN/AView Earnings Details
8/2/2011($0.10)($0.13)ViewN/AView Earnings Details
5/3/2011($0.09)($0.08)ViewN/AView Earnings Details
2/15/2011($0.08)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Exact Sciences Corporation (NASDAQ:EXAS)
Current Year EPS Consensus Estimate: $-1.69 EPS
Next Year EPS Consensus Estimate: $-1.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.54)($0.46)($0.51)
Q2 20164($0.56)($0.54)($0.55)
Q3 20164($0.55)($0.40)($0.51)
Q4 20164($0.42)($0.39)($0.41)
Q1 20173($0.44)($0.40)($0.41)
Q2 20173($0.40)($0.33)($0.37)
Q3 20173($0.40)($0.28)($0.34)
Q4 20173($0.36)($0.30)($0.33)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Exact Sciences Corporation (NASDAQ:EXAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Exact Sciences Corporation (NASDAQ:EXAS)
Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 86.54%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017D Scott CowardSVPSell1,535$13.61$20,891.35View SEC Filing  
12/14/2016David ThompsonDirectorBuy10,000$13.84$138,400.00View SEC Filing  
11/15/2016Kevin T ConroyInsiderSell600,000$17.46$10,476,000.00View SEC Filing  
11/15/2016Maneesh AroraCOOSell562,932$17.46$9,828,792.72View SEC Filing  
9/1/2016Lionel SterlingDirectorBuy5,000$18.10$90,500.00View SEC Filing  
8/3/2016Katherine S ZanottiDirectorBuy3,380$17.93$60,603.40View SEC Filing  
7/26/2016Graham Peter LidgardInsiderSell7,383$14.82$109,416.06View SEC Filing  
7/26/2016Maneesh AroraCOOSell7,359$14.82$109,060.38View SEC Filing  
4/1/2016D Scott CowardSVPSell1,685$6.62$11,154.70View SEC Filing  
3/10/2016D Scott CowardSVPSell2,175$6.05$13,158.75View SEC Filing  
3/10/2016Graham Peter LidgardInsiderSell3,041$6.05$18,398.05View SEC Filing  
3/10/2016Maneesh AroraCOOSell4,042$6.05$24,454.10View SEC Filing  
3/8/2016James Edward DoyleDirectorBuy5,000$6.43$32,150.00View SEC Filing  
3/3/2016Katherine S NapierDirectorBuy3,775$5.38$20,309.50View SEC Filing  
3/1/2016Kevin T ConroyCEOBuy50,000$5.00$250,000.00View SEC Filing  
2/26/2016Kevin T ConroyCEOSell6,895$5.81$40,059.95View SEC Filing  
2/25/2016Graham Peter LidgardInsiderSell2,997$5.52$16,543.44View SEC Filing  
2/25/2016Maneesh AroraCOOSell4,099$5.52$22,626.48View SEC Filing  
2/23/2016Graham Peter LidgardInsiderSell2,411$6.39$15,406.29View SEC Filing  
2/23/2016Kevin T ConroyCEOSell6,866$6.39$43,873.74View SEC Filing  
2/23/2016Maneesh AroraCOOSell2,556$6.39$16,332.84View SEC Filing  
1/11/2016David ThompsonDirectorBuy15,000$6.99$104,850.00View SEC Filing  
2/26/2015Graham Peter LidgardDirectorSell3,938$23.44$92,306.72View SEC Filing  
2/26/2015Kevin T ConroyCEOSell8,425$23.44$197,482.00View SEC Filing  
2/26/2015Maneesh AroraCOOSell3,895$23.44$91,298.80View SEC Filing  
2/24/2015Graham Peter LidgardDirectorSell4,037$22.90$92,447.30View SEC Filing  
2/24/2015Kevin T ConroyCEOSell9,798$22.90$224,374.20View SEC Filing  
2/24/2015Maneesh AroraCOOSell2,995$22.90$68,585.50View SEC Filing  
1/2/2015Graham Peter LidgardInsiderSell3,363$26.72$89,859.36View SEC Filing  
1/2/2015Kevin T ConroyCEOSell9,484$26.72$253,412.48View SEC Filing  
1/2/2015Maneesh AroraCOOSell2,495$26.72$66,666.40View SEC Filing  
10/29/2014Graham Peter LidgardInsiderSell8,015$24.68$197,810.20View SEC Filing  
7/25/2014Graham Peter LidgardVPSell11,081$15.99$177,185.19View SEC Filing  
7/25/2014Kevin T ConroyCEOSell11,336$15.99$181,262.64View SEC Filing  
7/25/2014Maneesh AroraCOOSell9,291$15.99$148,563.09View SEC Filing  
5/5/2014William MeganSVPBuy10,000$11.79$117,900.00View SEC Filing  
2/24/2014Graham Peter LidgardVPSell3,160$14.07$44,461.20View SEC Filing  
2/24/2014Kevin ConroyCEOSell8,708$14.07$122,521.56View SEC Filing  
2/24/2014Maneesh AroraCOOSell2,662$14.07$37,454.34View SEC Filing  
1/2/2014Graham Peter LidgardVPSell10,288$11.96$123,044.48View SEC Filing  
1/2/2014Kevin ConroyCEOSell26,379$11.96$315,492.84View SEC Filing  
1/2/2014Maneesh AroraCOOSell8,627$11.96$103,178.92View SEC Filing  
10/28/2013Graham Peter LidgardVPSell7,430$11.07$82,250.10View SEC Filing  
9/20/2013Sally CrawfordDirectorSell25,000$12.19$304,750.00View SEC Filing  
11/2/2012Kevin T ConroyCEOBuy2,000$9.13$18,260.00View SEC Filing  
11/2/2012Maneesh AroraCFOBuy1,000$9.04$9,040.00View SEC Filing  
11/1/2012Lionel SterlingDirectorBuy5,500$9.08$49,940.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Exact Sciences Corporation (NASDAQ:EXAS)
DateHeadline
News IconTraders Focused Stock: Exact Sciences Corporation's (EXAS) Stock price of $20.17 (NASDAQ:EXAS)
techknowbits.com - February 18 at 4:47 PM
News IconFeatured Stock Overview: Exact Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
xboxonezone.com - February 18 at 4:47 PM
News IconTaking a Look at the Data Behind Exact Sciences Corp. (EXAS) - StockNewsJournal (NASDAQ:EXAS)
stocknewsjournal.com - February 17 at 3:19 PM
News IconEarnings Clues on Exact Sciences Corporation (EXAS), Brocade Communications Systems, Inc. (BRCD) Analyst's ... - StockNewsJournal (NASDAQ:EXAS)
www.stocknewsjournal.com - February 17 at 3:19 PM
News IconInside Track: Trading Focus on Shares of Exact Sciences Corporation (EXAS) - Baldwin Journal (NASDAQ:EXAS)
baldwinjournal.com - February 17 at 3:19 PM
News IconThe Technical Facts on Exact Sciences Corporation (EXAS) - The USA Commerce (NASDAQ:EXAS)
www.theusacommerce.com - February 17 at 3:19 PM
News IconTaking a Look at the Data Behind Exact Sciences Corporation (EXAS) - StockNewsJournal (NASDAQ:EXAS)
stocknewsjournal.com - February 17 at 3:19 PM
News IconAnalyst's Proposition on PBF Energy Inc. (PBF), Exact Sciences Corporation (EXAS) (NASDAQ:EXAS)
hypelee.com - February 16 at 5:03 PM
nasdaq.com logoEXACT Sciences Reaches Analyst Target Price (NASDAQ:EXAS)
www.nasdaq.com - February 16 at 5:03 PM
finance.yahoo.com logoAlexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y (NASDAQ:EXAS)
finance.yahoo.com - February 16 at 5:03 PM
News IconAnalysts Take the Wheel on EXACT Sciences Corporation (NASDAQ:EXAS) Shares and Where They Might Be Headed - Aiken Advocate (NASDAQ:EXAS)
aikenadvocate.com - February 13 at 5:53 PM
News IconEPS Forecast Of EXACT Sciences Corporation (NASDAQ:EXAS) Set At $-0.3125 - Transcript Daily (NASDAQ:EXAS)
transcriptdaily.com - February 13 at 5:53 PM
News IconSell-Side Analyst's Predictions: Exact Sciences Corporation (EXAS), PBF Energy Inc. (PBF) - The USA Commerce (NASDAQ:EXAS)
theusacommerce.com - February 13 at 5:53 PM
realistinvestor.com logoEXACT Sciences Corporation (NASDAQ:EXAS) Is Expected To Post EPS Of $-0.3125 (NASDAQ:EXAS)
www.realistinvestor.com - February 12 at 5:03 PM
News IconWhat are Analyst's Indicators for Exact Sciences Corporation (EXAS), Summit Materials, Inc. (SUM) - The USA Commerce (NASDAQ:EXAS)
www.theusacommerce.com - February 9 at 10:44 PM
News IconTrading Views: Watching Shares of Exact Sciences Corporation (EXAS) - Benton Bulletin (NASDAQ:EXAS)
bentonbulletin.com - February 8 at 10:40 PM
News IconToday's Brokerage Rating: Exact Sciences Corporation (EXAS), Wayfair Inc. (W) - StockNewsJournal (NASDAQ:EXAS)
stocknewsjournal.com - February 8 at 10:40 PM
News IconEquity Focus: Zeroing in on Shares of Exact Sciences Corporation (EXAS) - Piedmont Register (NASDAQ:EXAS)
piedmontregister.com - February 7 at 6:19 PM
News IconInvestor Radar: Focusing in on Shares of Exact Sciences Corporation (NASDAQ:EXAS) - The Standard (NASDAQ:EXAS)
6milestandard.com - February 7 at 6:19 PM
News IconPrice Target Of EXACT Sciences Corporation (NASDAQ:EXAS)At $19 - Transcript Daily (NASDAQ:EXAS)
transcriptdaily.com - February 7 at 6:19 PM
News IconEXACT Sciences Corporation (NASDAQ:EXAS) Daily Sentiment Score At 0.28 - Stock Observer (NASDAQ:EXAS)
www.thestockobserver.com - February 7 at 6:19 PM
News IconAnalysts Near-Term outlook: Allison Transmission Holdings, Inc. (ALSN), Exact Sciences Corporation (EXAS) - The USA Commerce (NASDAQ:EXAS)
theusacommerce.com - February 7 at 6:19 PM
istreetwire.com logoMomentum Stocks: Macquarie Infrastructure Corporation (MIC), Exact Sciences Corporation (EXAS), Omega ... - iStreetWire (NASDAQ:EXAS)
istreetwire.com - February 6 at 10:31 AM
News IconExact Sciences Corporation (EXAS) receives average ‘hold’ rating (NASDAQ:EXAS)
news.xfoor.com - February 5 at 4:57 PM
News IconExact Sciences Corporation (EXAS) receives average 'hold' rating - TechNewsGazette (NASDAQ:EXAS)
technewsgazette.com - February 5 at 6:32 AM
News IconWhy Analysts put forward these two stocks: Sunoco Logistics Partners LP (SXL), Exact Sciences Corporation (EXAS) - The USA Commerce (NASDAQ:EXAS)
theusacommerce.com - February 3 at 5:29 PM
realistinvestor.com logoEXACT Sciences Corporation (NASDAQ:EXAS) Mean Rating At $2.11 - RealistInvestor.com (NASDAQ:EXAS)
www.realistinvestor.com - February 3 at 5:29 PM
streetinsider.com logoExact Sciences (EXAS) Announces CMS Proposes Inclusion of ... - StreetInsider.com (NASDAQ:EXAS)
www.streetinsider.com - February 3 at 3:46 AM
streetinsider.com logoExact Sciences (EXAS) Announces CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings (NASDAQ:EXAS)
www.streetinsider.com - February 2 at 5:38 PM
finance.yahoo.com logoCMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings (NASDAQ:EXAS)
finance.yahoo.com - February 2 at 5:38 PM
fool.com logoThe Sole Reason Exact Sciences Corporation Skyrocketed 42% in January (NASDAQ:EXAS)
www.fool.com - February 2 at 5:37 PM
finance.yahoo.com logoExact Sciences to participate in Leerink Partners Global Healthcare Conference (NASDAQ:EXAS)
finance.yahoo.com - February 1 at 5:41 PM
News IconEarnings Snapshot & Analysts Target Update on EXACT Sciences Corporation (NASDAQ:EXAS)? - Wall Street Beacon (NASDAQ:EXAS)
wsbeacon.com - January 31 at 10:51 PM
realistinvestor.com logoEPS Projection Of EXACT Sciences Corporation (NASDAQ:EXAS) At $-0.3125 - RealistInvestor.com (NASDAQ:EXAS)
www.realistinvestor.com - January 30 at 12:12 PM
News IconWhat are Research Firms Saying About EXACT Sciences Corporation (NASDAQ:EXAS)? - Aiken Advocate (NASDAQ:EXAS)
aikenadvocate.com - January 30 at 12:12 PM
News IconNext Weeks Broker Price Targets For EXACT Sciences Corporation (EXAS) (NASDAQ:EXAS)
mundoaguaysaneamiento.net - January 29 at 5:09 PM
News IconTraders Watch list: Exact Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
flapship.com - January 28 at 5:17 PM
realistinvestor.com logoMean Rating Of EXACT Sciences Corporation (NASDAQ:EXAS) At $2.11 - RealistInvestor.com (NASDAQ:EXAS)
www.realistinvestor.com - January 27 at 11:49 PM
News IconIs There Inherent Value in EXACT Sciences Corporation (NASDAQ:EXAS)? Analysts Delve Into The Stock - Wall Street Beacon (NASDAQ:EXAS)
wsbeacon.com - January 27 at 11:49 PM
News IconComputer Sciences Corporation (NYSE:CSC) Analyst Estimates And Rating (NASDAQ:EXAS)
prensariotiretail.com - January 27 at 6:47 PM
News IconThe Computer Sciences Corporation (CSC) Chairman John M. Lawrie Sells 3699 Shares (NASDAQ:EXAS)
mlbinjurynews.com - January 27 at 6:47 PM
us.rd.yahoo.com logoExact Sciences to host fourth-quarter, full-year 2016 results webcast and call (NASDAQ:EXAS)
us.rd.yahoo.com - January 26 at 11:35 PM
News IconEarnings in Full Force, Analysts Take Aim at EXACT Sciences Corporation (NASDAQ:EXAS) - Wall Street Beacon (NASDAQ:EXAS)
wsbeacon.com - January 26 at 6:33 PM
prnewswire.com logoExact Sciences to host fourth-quarter, full-year 2016 results webcast and call - PR Newswire (press release) (NASDAQ:EXAS)
www.prnewswire.com - January 26 at 6:33 PM
News IconExact Sciences Corporation (EXAS) Stock Price Decreases -4.99% (NASDAQ:EXAS)
myhealthbowl.com - January 25 at 6:27 PM
News IconImportant Analyst Opinions: Exact Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
vouxmagazine.com - January 24 at 10:46 PM
News IconInvestor Update: Tracking Shares of Exact Sciences Corporation (NASDAQ:EXAS) - The Tribune (NASDAQ:EXAS)
lakecitytribune.com - January 24 at 5:45 PM
News IconCrunching the Numbers for Exact Sciences Corporation (EXAS) - Springdale Times (NASDAQ:EXAS)
springdaletimes.com - January 23 at 10:29 PM
News IconAnalysts Pounding The Pavement on EXACT Sciences Corporation (NASDAQ:EXAS): Consensus Update - Wall Street Beacon (NASDAQ:EXAS)
wsbeacon.com - January 23 at 10:29 PM
News IconWorth Observing Stocks: FMC Corp. (NYSE:FMC), Exact Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
news.xfoor.com - January 23 at 10:30 AM

Social

What is Exact Sciences Corporation's stock symbol?

Exact Sciences Corporation trades on the NASDAQ under the ticker symbol "EXAS."

Where is Exact Sciences Corporation's stock going? Where will Exact Sciences Corporation's stock price be in 2017?

12 brokerages have issued 12 month price objectives for Exact Sciences Corporation's stock. Their forecasts range from $8.00 to $29.00. On average, they anticipate Exact Sciences Corporation's stock price to reach $19.91 in the next year.

When will Exact Sciences Corporation announce their earnings?

Exact Sciences Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.

What are analysts saying about Exact Sciences Corporation stock?

Here are some recent quotes from research analysts about Exact Sciences Corporation stock:

  • According to Zacks Investment Research, "EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated. " (1/24/2017)

  • Canaccord Genuity analysts commented, "We believe most investors consider EXAS a show-me" stock here and are looking for the company to beat numbers and make a major stride on the commercial payor front before entering or adding to positions. On the Q1 call, we expect: 1) data/updates on the company’s TV ad campaign, 2) a preliminary Q2 guide, and 3) an update on its co-marketing partnership with Ironwood Pharmaceuticals. Despite cautious investor sentiment on the stock, we continue to believe the risk/reward is to the upside at today’s levels." (5/2/2016)

Who owns Exact Sciences Corporation stock?

Exact Sciences Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (5.43%), State Street Corp (5.12%), Arrowpoint Asset Management LLC (2.86%), FMR LLC (1.60%), Orbimed Advisors LLC (0.88%) and Columbia Wanger Asset Management LLC (0.80%). Company insiders that own Exact Sciences Corporation stock include D Scott Coward, David Thompson, Graham Peter Lidgard, James Edward Doyle, Katherine S Napier, Katherine S Zanotti, Kevin T Conroy, Lionel Sterling and Maneesh Arora.

Who sold Exact Sciences Corporation stock? Who is selling Exact Sciences Corporation stock?

Exact Sciences Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Orbimed Advisors LLC, Trexquant Investment LP, Turner Investments LLC, State Board of Administration of Florida Retirement System, Pacad Investment Ltd., Baird Financial Group Inc. and Redmond Asset Management LLC. Company insiders that have sold Exact Sciences Corporation stock in the last year include D Scott Coward, Graham Peter Lidgard, Kevin T Conroy and Maneesh Arora.

Who bought Exact Sciences Corporation stock? Who is buying Exact Sciences Corporation stock?

Exact Sciences Corporation's stock was bought by a variety of institutional investors in the last quarter, including Arrowpoint Asset Management LLC, William Blair Investment Management LLC, State Street Corp, FIL Ltd, Columbia Wanger Asset Management LLC, Deerfield Management Co., A.R.T. Advisors LLC and Elkfork Partners LLC. Company insiders that have bought Exact Sciences Corporation stock in the last two years include David Thompson, James Edward Doyle, Katherine S Napier, Katherine S Zanotti, Kevin T Conroy and Lionel Sterling.

How do I buy Exact Sciences Corporation stock?

Shares of Exact Sciences Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Exact Sciences Corporation stock cost?

One share of Exact Sciences Corporation stock can currently be purchased for approximately $19.91.

Exact Sciences Corporation (NASDAQ:EXAS) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Exact Sciences Corporation (NASDAQ:EXAS)

Earnings History Chart

Earnings by Quarter for Exact Sciences Corporation (NASDAQ:EXAS)

Dividend History Chart

Dividend Payments by Quarter for Exact Sciences Corporation (NASDAQ:EXAS)

Last Updated on 2/19/2017 by MarketBeat.com Staff